|
|
|
|
| CHROMABOND® Drug II |
 |
Special silica phase for SPE of THC and derivatives
acidic analytes from biological fluids (urine, blood ...) |
| Features |
 |
Base material silica, pore size 60 Å, particle size 45 µm, specific surface 500 m2/g, pH stability 2–8
special bifunctional modification – C8 / SB (strong anion exchanger – quaternary amine) |
|
Recommended application:
extraction of THC and derivatives from urine, blood, serum, plasma (e.g., application 303880)
acidic analytes from biological fluids
For more applications click here. |
Ordering information
| |
|
Volume |
Adsorbent weight |
Pack of |
| |
 |
CHROMABOND® Drug II polypropylene columns |
| |
|
100 mg |
200 mg |
500 mg |
|
|
| |
1 mL |
730685 |
|
|
|
100 |
| |
3 mL |
|
730680 |
730686 |
|
50 |
| |
6 mL |
|
|
730683 |
|
30 |
| |
 |
CHROMABOND® LV-Drug II |
| |
|
|
200 mg |
|
|
|
| |
15 mL |
|
732681 |
|
|
30 |
| |
 |
CHROMABOND® MULTI 96 Drug II |
| |
|
|
|
|
96 x 100 mg |
|
| |
|
|
|
|
738680.100M |
1 |
| |
|
 |
|
|
 |